Cardiovascular Systems (CSII +0.4%) says it's enrolled the first patient in Liberty 360 study, a...

|About: Cardiovascular Systems, Inc. (CSII)|By:, SA News Editor

Cardiovascular Systems (CSII +0.4%) says it's enrolled the first patient in Liberty 360 study, a post-market evaluation of the acute and long-term clinical and economic effectiveness of its orbital atherectomy system in treating peripheral arterial disease. The study is unique in that it evaluates success based on long-term outcomes and durability, rather than acute angiographic results of the various treatments.